Gary J. Nabel - 08 Aug 2022 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Director
Signature
/s/ John Canepa, as Attorney-In-Fact for Gary Nabel
Issuer symbol
CADL
Transactions as of
08 Aug 2022
Net transactions value
$0
Form type
4
Filing time
10 Aug 2022, 08:05:18 UTC
Previous filing
24 Jun 2022
Next filing
08 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CADL Stock Option (Right to Buy) Award $0 +28,480 $0.000000 28,480 08 Aug 2022 Common Stock 28,480 $3.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 33% of the shares underlying this option shall vest and become exercisable on August 8, 2023, with the remainder vesting in two (2) equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date.